Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysis

被引:20
作者
Jin, Shan [1 ]
Tan, Shisheng [1 ]
Peng, Wen [1 ]
Jiang, Ying [1 ]
Luo, Chunshan [2 ]
机构
[1] Peoples Hosp Guizhou Prov, Dept Oncol, Guiyang, Peoples R China
[2] Guizhou Orthoped Hosp, Dept Orthoped, 184 Zhongshan East Rd, Guiyang 550000, Guizhou, Peoples R China
关键词
laparoscopic hepatectomy; radiofrequency ablation; hepatocellular carcinoma; meta-analysis; review; LIVER RESECTION; SURGICAL RESECTION; MILAN CRITERIA; SINGLE; SURGERY; CHEMOEMBOLIZATION; EFFICACY; OUTCOMES; SAFETY; CHINA;
D O I
10.1186/s12957-020-01966-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Several randomized controlled trials (RCTs) compared the effects of laparoscopic hepatectomy (LH) and radiofrequency ablation (RFA) for the treatment of hepatocellular carcinoma (HCC), but the results have remained inconsistent. Hence, a meta-analysis and a systematic review of these treatment modalities are necessary to evaluate their efficacy and safety for HCC treatment. Methods From the inception of this meta-analysis and review until August 31, 2019, we searched Medline, PubMed, EMBASE, Cochrane Library, China National Knowledge Infrastructure, Wanfang Database, and China Biomedical Literature Database for RCTs involving LH and RFA treatments of patients with HCC. The studies were screened and the data from these articles were extracted independently by two authors. Summary odd ratios (OR) or mean differences (MD) with 95% confidence intervals (CI) were calculated for each outcome with a fixed- or random-effect model. The outcomes for effectiveness evaluations included duration of surgery, estimated bleeding volume, incidence of blood transfusion during surgery, duration of hospital stay, and the outcome for safety included the incidence of cancer recurrence. Results Seven RCTs with a total of 615 patients were identified, 312 and 303 of which underwent RFA and LH treatments, respectively. The duration of surgery (MD = -99.04; 95% CI: -131.26--66.82), estimated bleeding volume (MD = -241.97; 95% CI: -386.93--97.02), incidence of blood transfusion during surgery (OR = 0.08; 95% CI: 0.02-0.37), and duration of hospital stay (MD = -3.4; 95% CI: -5.22--1.57) in RFA treatment were significantly lower than those of LH treatment. However, the incidence of cancer recurrence was significantly higher for RFA treatment compared with LH treatment (OR = 2.68; 95% CI: 1.72-4.18). Conclusions LH treatment is preferred over RFA treatment with a better radical effect, but RFA treatment is more beneficial with smaller trauma, development of less complications, and shorter operating time when compared with HCC treatment.
引用
收藏
页数:10
相关论文
共 43 条
[1]  
[Anonymous], 2016, SURG ENDOSC, DOI DOI 10.1007/S00464-015-4295-6
[2]  
[Anonymous], 2019, SURG ENDOSC, DOI DOI 10.1007/S00464-019-06784-0
[3]  
[Anonymous], 2015, SURG ENDOSC, DOI DOI 10.1007/S00464-014-3980-1
[4]  
[Anonymous], 2019, WORLD J GASTROENTERO, DOI DOI 10.3748/WJG.V25.I32.4614
[5]  
[Anonymous], 2017, CHIN CLIN ONCOL, DOI DOI 10.21037/CCO.2017.04.04
[6]  
[Anonymous], 2019, CANCER MANAG RES, DOI DOI 10.2147/CMAR.S189777
[7]  
[Anonymous], 2016, SURG ENDOSC, DOI DOI 10.1007/S00464-015-4737-1
[8]  
[Anonymous], 2018, J HEPATOL, DOI DOI 10.1016/J.JHEP.2018.02.026
[9]  
[Anonymous], 2002, J MED VIROL
[10]  
[Anonymous], 2017, SURG ENDOSC, DOI DOI 10.1007/S00464-016-5105-5